Last reviewed · How we verify
Rabbit Anti-thymocyte Immunoglobulin
Rabbit Anti-thymocyte Immunoglobulin is a Biologic drug developed by Sanofi. It is currently FDA-approved. Also known as: Thymoglobuline.
At a glance
| Generic name | Rabbit Anti-thymocyte Immunoglobulin |
|---|---|
| Also known as | Thymoglobuline |
| Sponsor | Sanofi |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation (PHASE2, PHASE3)
- Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis (PHASE4)
- Uterine Transplantation and Pregnancy Induction in Women Affected by Absolute Uterine Infertility (NA)
- Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients (PHASE2)
- A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes (PHASE1, PHASE2)
- Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders (PHASE2)
- Immune Tolerance Induction After Liver Transplantation (PHASE1, PHASE2)
- Allo HSCT for High Risk Hemoglobinopathies (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Rabbit Anti-thymocyte Immunoglobulin CI brief — competitive landscape report
- Rabbit Anti-thymocyte Immunoglobulin updates RSS · CI watch RSS
- Sanofi portfolio CI
Frequently asked questions about Rabbit Anti-thymocyte Immunoglobulin
What is Rabbit Anti-thymocyte Immunoglobulin?
Rabbit Anti-thymocyte Immunoglobulin is a Biologic drug developed by Sanofi.
Who makes Rabbit Anti-thymocyte Immunoglobulin?
Rabbit Anti-thymocyte Immunoglobulin is developed and marketed by Sanofi (see full Sanofi pipeline at /company/sanofi).
Is Rabbit Anti-thymocyte Immunoglobulin also known as anything else?
Rabbit Anti-thymocyte Immunoglobulin is also known as Thymoglobuline.
What development phase is Rabbit Anti-thymocyte Immunoglobulin in?
Rabbit Anti-thymocyte Immunoglobulin is FDA-approved (marketed).
Related
- Manufacturer: Sanofi — full pipeline
- Also known as: Thymoglobuline
- Compare: Rabbit Anti-thymocyte Immunoglobulin vs similar drugs
- Pricing: Rabbit Anti-thymocyte Immunoglobulin cost, discount & access